# Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 Hours in Patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valve Surgery

> **NCT01466452** · PHASE2 · UNKNOWN · sponsor: **Centro Cardiologico Monzino** · enrollment: 99 (estimated)

## Conditions studied

- Coronary Arteriosclerosis

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Aspirin
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT01466452
- **Lead sponsor:** Centro Cardiologico Monzino
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 99 (ESTIMATED)
- **Last updated:** 2011-11-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01466452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01466452, "Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 Hours in Patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valve Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01466452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*